Next-Gen Biologics
What do you see as the next big modality in biologics, and what factors are driving innovation in this space?
Pharma's Almanac
PAO-04-25-RT-01May 01, 2025
Series B Financing
Orum Therapeutics Announces $30 Million Series B Financing to Advance Cell-Penetrating, Cell-Specific Antibody Technology for Novel Therapeutics
Orum Therapeutics, Inc.
PR-M07-19-NI-052Jul 19, 2019